Wed 8/27/2014 10:54 ET
DJIA17114.888.560.05%SOLAR43.590.511.18%GOLD1282.400.220.22%Shanghai2209.472.430.11%
S&P 5001999.990.000.00%BANKS23.360.010.04%OIL94.0518.810.20%Nikkei15534.8213.980.09%
NASDAQ4570.370.460.01%SEMI50.850.150.29%US/EU0.760.210.27%Futures1996.002.600.13%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Applied Science & Technology Inc - ASTX   

ANNOUNCEMENT: Welcome back. TheLion.com has moved to a new service provider. Please report any issues to webmaster@thelion-inc.com. Thanks!

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add ASTX
  
From: all2tropical (Rep: 206)Date: 02/09/2012 13:47
Forum: Applied Science & Technology Inc - Msg #7Thread #673358445 (Rec: 0)
another one bites the dust...(H) DJ FDA's Oncologic Drugs Advisory Committee (ODAC) Votes To Not Support Benefit/Risk Profile Of DACOGEN(R) (decitabine) In Acute Myeloid Leukemia >ASTX
(MORE TO FOLLOW) Dow Jones Newswires (212-416-2400) February 09, 2012 13:46 ET (18:46 GMT) Copyright (c) 2012 Dow Jones & Company, Inc.- - 01 46 PM EST 02-09-12



Share This Post:


http://www.kirkreport.com/pictures/sumo_market.gif



***Disclaimer & Disclosure***: I make no guarantee as to the accuracy or validity of information in this message... 

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser all2tropical: Reward | Watch | IgnoreASTX: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add ASTX
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.